In conclusion, we found that the positivity of TTF‐1 expression was associated with PD‐L1 expression status, and that adenocarcinoma patients with positive TTF‐1 expression showed better ORR and PFS than those with negative TTF‐1 expression when treated with ICI monotherapy. Here, TTF1 is linked to adenocarcinoma.